pros and cons of microdosing tirzepatide GLP-1 microdosing is popular, but

This state-of-the-art treatment is designed to target and reduce body fat, helping you progress towards your weight loss goals while simultaneously boosting your overall health

Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis

On April 30, 2026, the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list, citing no clinical need for large-scale compounding of these drugs

Cardiovascular safety of antidiabetic medications has received increasing attention since 2008 and here we summarize the recent updates from both clinical trials and preclinical experiments on the cardiovascular outcomes of this class of glucose-lowering drugs